Quarterly Results

ZIM LABORATORIES LTD.

NSE : ZIMLABBSE : 541400ISIN CODE : INE518E01015Industry : Pharmaceuticals & DrugsHouse : MNC
BSE118.90-1.7 (-1.41 %)
PREV CLOSE ( ) 120.60
OPEN PRICE ( ) 121.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 39895
TODAY'S LOW / HIGH ( )117.85 126.95
52 WK LOW / HIGH ( )79.5 128.45
NSE118.87-1.95 (-1.61 %)
PREV CLOSE( ) 120.82
OPEN PRICE ( ) 122.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 118.87 (126)
VOLUME 980447
TODAY'S LOW / HIGH( ) 118.00 127.00
52 WK LOW / HIGH ( )79.49 128.9
Quarters
Select year  
( in Million)
Particulars
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1087.33
963.3
921.43
818.24
Total Expenditure
941.37
847.67
826.12
737.87
PBIDT (Excl OI)
145.96
115.63
95.30
80.37
Other Income
17.1
17.55
13.21
9.99
Operating Profit
163.06
133.18
108.52
90.36
Interest
29.09
27.33
28.88
28.59
Exceptional Items
NA
NA
NA
NA
PBDT
133.97
105.85
79.64
61.77
Depreciation
52.89
48.81
50.01
49.43
Profit Before Tax
81.07
57.04
29.63
12.34
Tax
32.24
17.03
5.82
3.36
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
48.83
40.01
23.81
8.98
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
48.83
40.01
23.81
8.98
Minority Interest
0.00
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
48.85
40.01
23.81
8.98
Equity Capital
487.26
487.26
487.26
487.26
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
1.00
0.82
0.48
0.18
Calculated EPS (Annualised)
4.01
3.28
1.95
0.73
No of Public Share Holdings
32517834
32517834
32517834
32517834
% of Public Share Holdings
66.74
66.74
66.74
66.74
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
13.42
12.00
10.34
9.82
PBIDTM%
14.99
13.82
11.77
11.04
PBDTM%
12.32
10.98
8.64
7.54
PBTM%
7.45
5.92
3.21
1.50
PATM%
4.49
4.15
2.58
1.09
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.